Delivery of drugs

Aikaterini Lalatsa (Inventor)

Research output: Patent


The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.
Original languageEnglish
Patent numberPCT/GB2014/053254,
IPCA61K 47/36 (2006.01), A61K 38/08 (2006.01)
Priority date4/11/14
Publication statusPublished - 7 May 2015


  • Peptide, Nanomedicines, Nasal


Dive into the research topics of 'Delivery of drugs'. Together they form a unique fingerprint.

Cite this